… of dabigatran on the cellular and protein phase of coagulation in patients with coronary
artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a …

… Adjunctive integral of hemostatic risk factors such as clot strength … In another analysis to
evaluate the impact of impaired fibrinolytic … Levels of platelet cell adhesion molecules and bound …

… array of receptors and adhesion molecules and are ultimately … ; numerous coagulation,
anticoagulation, fibrinolytic, and … Clopidogrel plus aspirin versus oral anticoagulation for atrial …

… Furthermore, cell adhesion molecules accelerate not only … , indicating a link between
hemostasis and immunity, setting … myocardial infarction after treatment with clopidogrel as well as …

… Coronary artery disease continues to be a leading cause of … that functions as an
adhesion molecule on the surface of … and clopidogrel, with less impact on hemostasis [Citation127]. …

… patients with stable coronary artery disease undergoing PCI. … with clopidogrel for stable
patients whose coronary anatomy … heart surgery are platelet dysfunction, enhanced fibrinolysis, …

… this process is called fibrinolysis. Normally, hemostasis and fibrinolysis are finely regulated
… poor metabolism of clopidogrel, resulting in inadequate drug effect and ultimately leading to …

… that platelets are crucial for human hemostasis, is based on … to recruit leukocytes, upregulate
adhesion molecules by EC and … percutaneous coronary intervention and/or fibrinolysis …

… adhesion molecule (ICAM-1) and vascular cell adhesion … ROS affecting the processes of
coagulation, fibrinolysis, … and clopidogrel alone in patients with a previous ischemic stroke and …

… Clopidogrel is a widely-used antiplatelet drug. It is important for the treatment and prevention
of coronary heart disease. Clopidogrel can effectively reduce platelet activity and therefore …